Immersive Virtual Reality Reminiscence Reduces Anxiety in the Oldest-Old Without Causing Serious Side Effects: A Single-Center, Pilot, and Randomized Crossover Study
Open accessAbstract
Background: Dementia is one the major problems of aging societies, and, novel and effective non-drug therapies are required as interventions in the oldest-old to prevent cognitive decline. Objective: This study aims to examine the efficacy and safety of reminiscence using immersive virtual reality (iVR reminiscence) focusing on anxiety that often appears with cognitive decline. The secondary objective is to reveal the preference for VR image types for reminiscence: live-action (LA) or computer graphics (CG). Methods: This was a pilot, open-label, and randomized crossover study which was conducted on January 2020 at a single nursing home. The subjects were randomly divided into two groups (A or B) in equal numbers, and they alternately viewed two types of VR images (LA and CG) themed on the mid- to late Showa era (A.D. 1955–1980) in Japan. In group A, the CG images were viewed first, and then the LA images were viewed (CG→ LA). In group B, the images were viewed in the opposite order (LA→ CG). Before VR viewing, subjects responded to Mini-Mental State Examination (MMSE) Japanese version and State-Trait Anxiety Inventory (STAI) Japanese version. After viewing the first and second VR, subjects responded to STAI and the numerical rating scale (NRS) for satisfaction and side effects (nausea, dizziness, headache, and tiredness). Results: Ten subjects participated in this study. The values of analyses are presented in the mean (SD). The age was 87.1 years (4.2), and the MMSE was 28.5 (1.8). The total STAI score before VR viewing was 36.1 (7.2), but it significantly decreased to 26.8 (4.9) after the first VR viewing (P = 0.0010), and further decreased to 23.4 (2.8) after the second VR viewing (P < 0.001). The NRS score for satisfaction tended to be higher after viewing LA in group A (CG→ LA) (CG vs. LA; 7.0 (2.3) vs. 8.6 (1.5), P = 0.0993), while in group B (LA→ CG), the score after CG was slightly lower than that after LA. There were no serious side effects. Conclusions: This study suggests that iVR reminiscence can reduce anxiety in the oldest-old without causing serious side effects. Furthermore, the impacts might be better with LA images.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The reminiscence program helped reduce anxiety among residents in a Japanese LTC home.
“The reminiscence program of Niki et al. (2021) helped reduced anxiety among residents in a Japanese LTC home.”
From Facilitators and Barriers to Using Virtual Reality and its Impact on Social Engagement in Aged Care Settings: A Scoping Review (2023) · cites this paper as Niki et al. (2021)
The Discussion reports that immersive VR reminiscence could transiently reduce anxiety. However, Materials and Methods > Subjects describes participants as people aged 75 or older using day services at a nursing home, not necessarily residents. The claim's description of them as residents is therefore unsupported. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Ngandu, T., Lehtisalo, J., Solomon, A., Levälahti, E., Ahtiluoto, S., Antikainen, R., Bäckman, L., Hänninen, T., Jula, A., Laatikainen, T., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60461-5 · Cited by 3,689 · see citing works
Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease
Honig, L. S., Vellas, B., Woodward, M., Boada, M., Bullock, R., Borrie, M., Hager, K., Andreasen, N., Scarpini, E., Liu-Seifert, H., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1705971 · Cited by 1,049 · cited 1× · see citing works
“More recently, a series of phase 3 trials of new dementia drug candidates (Salloway et al., 2014; Honig et al., 2018; Wessels et al., 2019) ended in failure, highlighting the limitations of drug therapy for dementia.”
BackgroundRolland, Y., Pillard, F., Klapouszczak, A., Reynish, E., Thomas, D., Andrieu, S., Rivière, D., & Vellas, B. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01035.x · Cited by 661 · see citing works
Ueda, T., Suzukamo, Y., Sato, M., & Izumi, S.-I. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.02.003 · Cited by 330 · see citing works
Incorporating telemedicine as part of COVID-19 outbreak response systems
(2020) · The American Journal of Managed Care · doi:10.37765/ajmc.2020.42784 · Cited by 272 · see citing works
Preschl, B., Maercker, A., Wagner, B., Forstmeier, S., Baños, R. M., Alcañiz, M., Castilla, D., & Botella, C. (2012) · Aging & Mental Health · doi:10.1080/13607863.2012.702726 · Cited by 86 · see citing works
Yury, C. A., & Fisher, J. E. (2007) · Psychotherapy and Psychosomatics · doi:10.1159/000101499 · Cited by 63 · see citing works
Virtual Reality for Therapeutic Recreation in Dementia Hospice Care: A Feasibility Study
Ferguson, C., Shade, M. Y., Blaskewicz Boron, J., Lyden, E., & Manley, N. A. (2020) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/1049909120901525 · Cited by 57 · see citing works
Flagged first, then by citations
Research works printed but not linked: 37
- Barnes D. E. Yaffe K. (2011). The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol. 10, 819– 828. 10.1016/S1474-4422(11)70072-2 21775213 PMC3647614 · DOI
- Belland L. Rivera-Reyes L. Hwang U. (2017). Using music to reduce anxiety among older adults in the emergency department: a randomized pilot study. J. Integr. Med. 15, 450– 455. 10.1016/S2095-4964(17)60341-8 29103414 · DOI
- Black W. Almeida O. P. (2004). A systematic review of the association between the behavioral and psychological symptoms of dementia and burden of care. Int. Psychogeriatr. 16, 295– 315. 10.1017/S1041610204000468 15559754 · DOI
- Butler R. N. (1963). The life review: an interpretation of reminiscence in the aged. Psychiatry 26, 65– 76. 10.1080/00332747.1963.11023339 14017386 · DOI
- Chirico A. Maiorano P. Indovina P. Milanese C. Giordano G. G. Alivernini F.. (2020). Virtual reality and music therapy as distraction interventions to alleviate anxiety and improve mood states in breast cancer patients during chemotherapy. J. Cell Physiol. 235, 5353– 5362. 10.1002/jcp.29422 31957873 · DOI
- Gitlin L. N. Winter L. Burke J. Chernett N. Dennis M. P. Hauck W. W. (2008). Tailored activities to manage neuropsychiatric behaviors in persons with dementia and reduce caregiver burden: a randomized pilot study. Am. J. Geriatr. Psychiatry. 16, 229– 239. 10.1097/01.JGP.0000300629.35408.94 18310553 PMC2803044 · DOI · Paper page
- Goldwasser A. N. Auerbach S. M. Harkins S. W. (1987). Cognitive, affective, and behavioral-effects of reminiscence group-therapy on demented elderly. Int. J. Aging Hum. Dev. 25, 209– 222. 10.2190/8UX8-68VC-RDYF-VK4F 3429043 · DOI
- Guan W. J. Ni Z. Y. Hu Y. Liang W. H. Ou C. Q. He J. X. (2020). Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 382, 1708– 1720. 10.1056/NEJMoa2002032 32109013 PMC7092819 · DOI · Paper page
- Hauer K. Schwenk M. Zieschang T. Essig M. Becker C. Oster P. (2012). Physical training improves motor performance in people with dementia: a randomized controlled trial. J. Am. Geriatr. Soc. 60, 8– 15. 10.1111/j.1532-5415.2011.03778.x 22211512 · DOI
- Hermans D. G. Hla H. U. McShane R. (2007). Non-pharmacological interventions for wandering of people with dementia in the domestic setting. Cochrane Database Syst. Rev. 1: CD005994. 10.1002/14651858.CD005994.pub2 17253573 PMC6669244 · DOI
- Huang H. C. Chen Y. T. Chen P. Y. Hu S. H. L. Liu F. Kuo Y. L.. (2015). Reminiscence therapy improves cognitive functions and reduces depressive symptoms in elderly people with dementia: a meta-analysis of randomized controlled trials. J. Am. Med. Dir. Assoc. 16, 1087– 1094. 10.1016/j.jamda.2015.07.010 26341034 · DOI
- Humphreys J. Schoenherr L. Elia G. Saks N. T. Brown C. Barbour S.. (2020). Rapid implementation of inpatient telepalliative medicine consultations during COVID-19 pandemic. J. Pain Symptom. Manage. 60, e54– e59. 10.1016/j.jpainsymman.2020.04.001 32283219 PMC7151239 · DOI
- Iwata N. Mishima N. Shimizu T. Mizoue T. Fukuhara M. Hidano T.. (1998a). Positive and negative affect in the factor structure of the State-Trait Anxiety Inventory for Japanese workers. Psychol. Rep. 82, 651– 656. 10.2466/pr0.1998.82.2.651 9621742 · DOI
- Iwata N. Mishima N. Shimizu T. Mizoue T. Fukuhara M. Hidano T. (1998b). The Japanese adaptation of the STAI Form Y in Japanese working adults–the presence or absence of anxiety. Ind. Health 36, 8– 13. 10.2486/indhealth.36.8 9473852 · DOI
- Kaufer D. I. Williams C. S. Braaten A. J. Gill K. Zimmerman S. Sloane P. D. (2008). Cognitive screening for dementia and mild cognitive impairment in assisted living: comparison of 3 tests. J. Am. Med. Dir. Assoc. 9, 586– 593. 10.1016/j.jamda.2008.05.006 19083293 · DOI
- Korte J. Bohlmeijer E. T. Cappeliez P. Smit F. Westerhof G. J. (2012). Life review therapy for older adults with moderate depressive symptomatology: a pragmatic randomized controlled trial. Psychol. Med. 42, 1163– 1173. 10.1017/S0033291711002042 21995889 · DOI
- Krolak-Salmon P. Dubois B. Sellal F. Delabrousse-Mayoux J. P. Vandel P. Amieva H.. (2018). France will no more reimburse available symptomatic drugs against Alzheimer's disease. J. Alzheimers Dis. 66, 425– 427. 10.3233/JAD-180843 30282371 · DOI
- Laurin D. Verreault R. Lindsay J. MacPherson K. Rockwood K. (2001). Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch. Neurol. 58, 498– 504. 10.1001/archneur.58.3.498 11255456 · DOI · Paper page
- Li Q. Guan X. Wu P. Wang X. Zhou L. Tong Y.. (2020). Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N. Engl. J. Med. 382, 1199– 1207. 10.1056/NEJMoa2001316 31995857 PMC7121484 · DOI · Paper page
- Livingston G. Sommerlad A. Orgeta V. Costafreda S. G. Huntley J. Ames D.. (2017). Dementia prevention, intervention, and care. Lancet 390, 2673– 2734. 10.1016/S0140-6736(17)31363-6 28735855 · DOI · Paper page
- Lok N. Bademli K. Selcuk-Tosun A. (2019). The effect of reminiscence therapy on cognitive functions, depression, and quality of life in Alzheimer patients: randomized controlled trial. Int. J. Geriatr. Psychiatry. 34, 47– 53. 10.1002/gps.4980 30246408 · DOI
- Milner B. Squire L. R. Kandel E. R. (1998). Cognitive neuroscience and the study of memory. Neuron 20, 445– 468. 10.1016/S0896-6273(00)80987-3 9539121 · DOI
- Moon S. Park K. (2020). The effect of digital reminiscence therapy on people with dementia: a pilot randomized controlled trial. BMC Geriatr. 20, 166. 10.1186/s12877-020-01563-2 32375661 PMC7204054 · DOI
- Mori M. MacDorman K. F. Kageki N. (2012). The uncanny valley [from the field]. IEEE Robot. Automat. Magazine 19, 98– 100. 10.1109/MRA.2012.2192811 · DOI · Paper page
- Niki K. Okamoto Y. Maeda I. Mori I. Ishii R. Matsuda Y. (2019). A novel palliative care approach using virtual reality for improving various symptoms of terminal cancer patients: a preliminary prospective, multicenter study. J. Palliat. Med. 22, 702– 707. 10.1089/jpm.2018.0527 30676847 · DOI · Paper page
- Ohannessian R. Duong T. A. Odone A. (2020). Global telemedicine implementation and integration within health systems to fight the COVID-19 pandemic: a call to action. JMIR Public Health Surveill. 6: e18810. 10.2196/18810 32238336 PMC7124951 · DOI · Paper page
- Salloway S. Sperling R. Fox N. C. Blennow K. Klunk W. Raskind M.. (2014). Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. N. Engl. J. Med. 370, 322– 333. 10.1056/NEJMoa1304839 24450891 PMC4159618 · DOI · Paper page
- Santana-Sosa E. Barriopedro M. I. Lopez-Mojares L. M. Perez M. Lucia A. (2008). Exercise training is beneficial for Alzheimer's patients. Int. J. Sports Med. 29, 845– 850. 10.1055/s-2008-1038432 18401810 · DOI
- Saxton J. Morrow L. Eschman A. Archer G. Luther J. Zuccolotto A. (2009). Computer assessment of mild cognitive impairment. Postgrad. Med. 121, 177– 185. 10.3810/pgm.2009.03.1990 19332976 PMC2699993 · DOI
- Schutte N. S. Stilinovi,ć E. J. (2017). Facilitating empathy through virtual reality. Motiv. Emot. 41, 708– 712. 10.1007/s11031-017-9641-7 · DOI · Paper page
- Subramaniam P. Woods B. (2016). Digital life storybooks for people with dementia living in care homes: an evaluation. Clin. Interv. Aging. 11, 1263– 1276. 10.2147/CIA.S111097 27698556 PMC5034922 · DOI
- Sugishita M. Itsumi I. Takeuchi T. (2016). Reexamination of the validity and reliability of the Japanese version of the Mini-Mental State Examination (MMSE-J). Japan. J. Cogn. Neurosci. 18, 168– 183. 10.11253/ninchishinkeikagaku.18.168 · DOI
- Thomas V. S. Hageman P. A. (2003). Can neuromuscular strength and function in people with dementia be rehabilitated using resistance-exercise training? Results from a preliminary intervention study. J. Gerontol. A Biol. Sci. Med. Sci. 58, 746– 751. 10.1093/gerona/58.8.M746 12902534 · DOI
- Wang J. J. (2007). Group reminiscence therapy function of demented elderly for cognitive and affective in Taiwan. Int. J. Geriatr. Psychiatry. 22, 1235– 1240. 10.1002/gps.1821 17503545 · DOI
- Wang S. S. Y. Teo W. Z. W. Teo W. Z. Y. Chai Y. W. (2020). Virtual reality as a bridge in palliative care during COVID-19. J. Palliat. Med. 23: 756. 10.1089/jpm.2020.0212 32324080 · DOI
- Wessels A. M. Tariot P. N. Zimmer J. A. Selzler K. J. Bragg S. M. Andersen S. W.. (2019). Efficacy and safety of lanabecestat for treatment of early and mild Alzheimer disease: the AMARANTH and DAYBREAK-ALZ randomized clinical trials. JAMA Neurol. 77, 199– 209. 10.1001/jamaneurol.2019.3988 31764959 PMC6902191 · DOI
- Zhu N. Zhang D. Wang W. Li X. Yang B. Song J. (2020). A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382, 727– 733. 10.1056/NEJMoa2001017 31978945 PMC7092803 · DOI · Paper page
Cited by
Sorted by citations
Hung, L., Mann, J., Wallsworth, C., Upreti, M., Kan, W., Temirova, A., Wong, K. L. Y., Ren, H., To-Miles, F., Wong, J., et al. (2023) · Gerontology and Geriatric Medicine · doi:10.1177/23337214231166355 · Cited by 48 · see citing works
“The reminiscence program of Niki et al. (2021) helped reduced anxiety among residents in a Japanese LTC home.”
Background
- Authors
- Niki, K., Yahara, M., Inagaki, M., Takahashi, N., Watanabe, A., Okuda, T., Ueda, M., Iwai, D., Sato, K., & Ito, T.
- Affiliations
- Ashiya Municipal Hospital (JP)
- The University of Osaka (JP)
- Osaka Center for Cancer and Cardiovascular Disease Prevention (JP)
- Corresponding author
- Niki, Kazuyuki
- Venue
- Frontiers in Human Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2021-01-18
- Volume
- 14
- Pages
- 598161-598161
- ISSN
- 1662-5161 (ISSN-L)
- PMC
- PMC7849024
- OpenAlex
- W3121976989
- Cited by
- 80
- References
- 8
- Citations by year
- 2026: 12 · 2025: 23 · 2024: 16 · 2023: 15 · 2022: 10 · 2021: 4
- FWCI
- 6.90
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Human Neuroscience (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Physical Sciences › Computer Science › Human-Computer Interaction › Virtual Reality Applications and Impacts
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Social Sciences › Arts and Humanities › Conservation › Art Therapy and Mental Health
- Keywords
- immersive virtual reality, reminiscence, anxiety reduction, oldest old, nursing home residents, dementia, cognitive decline, non-pharmacological treatment, adverse effects, user satisfaction, reminiscence therapy, nursing homes, cognitive decline prevention, anxiety in older adults
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review